HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) in ameloblastomas correlate with rupture of the osseous cortical.

Abstract
Myofibroblasts are frequent in the stroma of neoplasm and by the expression of proteinases they can influence tumor infiltration and progression. In the present study, presence of myofibroblasts and expression of matrix metalloproteinase-2 (MMP-2) and urokinase plasminogen activator (uPA) were examined in intra-osseous solid multicystic ameloblastomas to determine their roles in the clinicopathological features of the tumors. Fifty seven ameloblastomas were analyzed immunohistochemically with antibodies against the isoform alpha of the smooth muscle actin (alpha-SMA), a specific marker of myofibroblasts, MMP-2 and uPA. Myofibroblasts were found in the stroma, in close contact with neoplastic cell islands, of approximately 58% (n = 33) of the ameloblastomas. MMP-2 and uPA were found in the cytoplasm of both neoplastic and stromal cells. A significant correlation between presence of myofibroblasts and MMP-2 expression was observed. Abundant presence of myofibroblast in the stroma of the tumors and expression of MMP-2 in the neoplastic or stromal cells were significantly correlated with rupture of the osseous cortical, which has been considered an important prognostic marker of ameloblastoma aggressiveness. Ours results suggest that abundant presence of myofibroblasts and expression of MMP-2 in solid ameloblastomas may be associated with a more aggressive infiltrative behavior.
AuthorsEduardo Rodrigues Fregnani, Lays M Sobral, Fabio Abreu Alves, Fernando Augusto Soares, Luis Paulo Kowalski, Ricardo D Coletta
JournalPathology oncology research : POR (Pathol Oncol Res) Vol. 15 Issue 2 Pg. 231-40 (Jun 2009) ISSN: 1219-4956 [Print] Switzerland
PMID19096916 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers, Tumor
  • Urokinase-Type Plasminogen Activator
  • Matrix Metalloproteinase 2
Topics
  • Adolescent
  • Adult
  • Aged
  • Ameloblastoma (enzymology, pathology)
  • Biomarkers, Tumor (metabolism)
  • Bone Neoplasms (enzymology, pathology)
  • Child
  • Cytoplasm (metabolism)
  • Disease Progression
  • Female
  • Fibroblasts (metabolism, pathology)
  • Humans
  • Male
  • Matrix Metalloproteinase 2 (metabolism)
  • Middle Aged
  • Muscle, Smooth (enzymology)
  • Prognosis
  • Stromal Cells (enzymology)
  • Urokinase-Type Plasminogen Activator (metabolism)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: